Skip to main content
Rx Summit 2020 Event Banner
* indicates a required field

2020 Call for Presentations is now CLOSED

The submission portal is now closed. Please contact Cindy Lackey ( or Kristy Ward ( for any further assistance.

Event Date: April 13 - 16, 2020
Location: Gaylord Opryland Resort & Convention Center in Nashville, TN
Submission Deadline Date: Friday, August 23, 2019

The Rx Summit will notify applicants by the end of November 2019 regarding whether their submission was accepted or declined.

Please read before submitting a presentation proposal.

The Rx Drug Abuse & Heroin Summit is the largest national collaboration of professionals from local, state and federal agencies, business, academia, clinicians, treatment providers, counselors, educators, state and national leaders, law enforcement/ public safety, and advocates impacted by the opioid crisis.

The session programs and presentations will be tailored to provide stakeholders timely and relevant information for their particular fields. Submissions will be reviewed by the Rx Summit’s National Advisory Board members, who represent multi-disciplinary interests.

Please be prepared to submit the following:
  • Session/Poster title
  • Abstract (Max 250 words)
  • Three (3) learning objectives
  • Three (3) practical take-aways
  • Identification of topic area (listed below)
  • Speaker details to include profile information & conflict of interest documentation

  • The Summit will be accepting presentation proposals that accommodate the following formats:
  • Breakout Sessions (75-minutes, including a question and answer segment)
  • Posters (which will be featured in the exhibit hall and have designated poster presentation times where presenters will be required to stand by their posters)

  • Limit of 4 breakout session presenters (2 is preferred). Up to 2 presenters are eligible for complimentary registration and travel reimbursement (see Presentation Terms and Conditions). Limit of 1 poster presenter.

    Limit of 3 proposals per submitter.

    All submission presenters will be required to agree to the Rx Summit Presentation Terms and Conditions before a proposal can be submitted.

    Note: The Rx Summit National Advisory Board will accept presenter applications based on the following criteria:
  • Supporting evidence-based data from research or demonstrated results.
  • Intent to provide details on how to implement a successful program for others to replicate.

  • The Rx Summit National Advisory Board is seeking proposals that correspond to the following topic areas:

    (Please note that these are the categories for the submission process only, and do not correspond to actual tracks at the Rx Summit. Track definitions and the number of tracks will be determined during the review process.)

    Advocacy – Activities and programs developed by community organizations, faith and family groups, prevention and education networks, public health agencies (local, state, federal, etc.), or private organizations that support legislative, community, and family support programs.

    Clinical – Strategies and outcomes that further the understanding of how to manage patients’ pain safely, address patients' addiction issues, mitigate risks associated with Rx opioids, and address health issues related to the opioid crisis (such as HIV and Hepatitis C infections) in all age demographics from pre-natal/NAS to older adults, as well as how to set up clinical practices to respond to the opioid crisis.

    Cocaine, Meth & Stimulants – The opioid crisis is making headlines, but another category of drugs continues to devastate communities: stimulants. For the first time ever, the Rx Summit will be hosting a post-conference workshop designed to address the country’s stimulant crisis.

    Emergency Medical Services / First Responders – Current and future innovative strategies that address EMS and first responders’ role in treating and managing substance use disorder. Case presentations identifying novel and successful assessments, partnerships, stakeholder collaboration, provider and patient mental health, management and treatment plans as well as destination and follow-up options for patients.

    Harm Reduction Strategies – Practical strategies and active programs aimed at reducing the negative consequences associated with drug use, such as overdose prevention, supervised injection facilities, field-based drug testing, and syringe access.

    Heroin & Other Illicit Drugs – Statistical analysis of emerging threats as well as new initiatives and proven strategies of policy, public health, and law enforcement tactics of federal, state, and local responses that have been implemented to respond to ever-changing drug use patterns, such as with heroin, fentanyl, and gabapentin.

    Law Enforcement & Corrections – Case studies from the federal, state, local and tribal agencies, prosecutors, correctional institutions, judicial systems who are implementing enforcement, treatment, and programs that identify new opportunities for prevention with stakeholders outside the law enforcement community.

    PDMP & Data Surveillance – Federal, state, and local systems and strategies that formulate and improve the effective data gathering, sharing, and analysis through provider engagement and technology innovations.

    Prescription Practices / Third Party Payer – Proven prescription best practices, case studies, and policies and legislation from pharmacists and pharmacy benefit managers, dentists, anesthesiologists, as well as programs and successful efforts with commercial and employee health plans, workers’ compensation, and Medicare and Medicaid plans.

    Prevention Strategies – Research and proven programs that seek to prevent initial substance use; including the study of drug trends and responses, alternative pain management strategies, crafting communication and social media campaigns; and the implementation of effective youth prevention programs, including peer-to-peer models.

    Rural & Tribal Communities – Programs and initiatives being implemented to address the opioid epidemic in these hard-hit areas of the United States, and often lacking the necessary resources needed to adequately address prevention and initiate treatment on a system-wide level.

    Treatment & Recovery – Successful, outcome-based treatment and recovery programs in response to the opioid epidemic, including the discussion of the opportunities and challenges created by new federal laws, and treatment and recovery efforts for diverse populations, including veterans, older adults, etc.

    Workplace – Real-world examples of employers hiring people in recovery, addressing opioid use among their workforce, connecting employees to treatment, and supporting workers' recovery, including public-private partnerships.

    Click here to download and review the Submission Guidelines.
    Click here to download the Abstract Frequently Asked Questions.

    Questions: Cindy Lackey at OR Kristy Ward at

    Log in to the Abstract ScoreCard

    Questions? Organizer: Cindy Lackey -